A federal Centers for Disease Control and Prevention’s advisory panel is weighing recommendations for RSV vaccines for older adults and pregnant people and a monoclonal antibody for babies and toddlers.
Respiratory syncytial virus infects nearly everyone by age 2, usually causing nothing beyond cold symptoms. But it’s also the leading cause of hospitalizations among children under 5. RSV also causes more than 177,000 hospitalizations and 14,000 deaths a year among older adults.
